|
ZHX2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.49569245877501E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.0173976912381E-11 |
| Normal-vs-Stage2 |
8.321600E-03 |
| Normal-vs-Stage3 |
6.70629999977024E-07 |
| Normal-vs-Stage4 |
3.80730000000273E-05 |
| Stage1-vs-Stage2 |
6.524400E-01 |
| Stage1-vs-Stage3 |
5.473000E-01 |
| Stage1-vs-Stage4 |
4.562600E-01 |
| Stage2-vs-Stage3 |
9.535400E-01 |
| Stage2-vs-Stage4 |
9.545400E-01 |
| Stage3-vs-Stage4 |
8.705200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.80209189185143E-12 |
| Normal-vs-AfricanAmerican |
5.628800E-04 |
| Normal-vs-Asian |
1.209390E-04 |
| Caucasian-vs-AfricanAmerican |
2.450200E-01 |
| Caucasian-vs-Asian |
9.650800E-01 |
| AfricanAmerican-vs-Asian |
3.344000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.95849999995446E-06 |
| Normal-vs-Female |
3.48054918219987E-12 |
| Male-vs-Female |
4.398400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.9539004575696E-10 |
| Normal-vs-Age(41-60Yrs) |
2.37869945962643E-10 |
| Normal-vs-Age(61-80Yrs) |
6.460700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.449000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.068800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.738100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.799200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.191700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.181000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.331600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.604420E-01 |
| Classical-VS-Follicular |
1.87509999971525E-07 |
| Classical-VS-Other |
1.228760E-01 |
| Classical-VS-Normal |
1.62470037423645E-12 |
| Tall-VS-Follicular |
7.516400E-03 |
| Tall-VS-Other |
1.989800E-01 |
| Tall-VS-Normal |
1.171710E-04 |
| Follicular-VS-Other |
8.652000E-01 |
| Follicular-VS-Normal |
3.551200E-01 |
| Other-VS-Normal |
6.070200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.96730000015621E-07 |
| Normal-vs-N1 |
6.379300E-03 |
| N0-vs-N1 |
5.284800E-01 |
|
|
